DaChan Food (Asia) Limited
3999.HK · Hong Kong Stock Exchange · HKD
0,58HKD
+0,035 (+6,42 %)Stand 9. Nov., 7:54
Kennzahlen
- Eröffnung
- 0,525
- Vortag
- 0,545
- Tagesspanne
- 0,525 – 0,58
- 52 Wochen
- 0,455 – 0,68
- Volumen
- 3000
- Ø Volumen
- 11.700
- Börsenwert
- 589,39 Mio. HKD
- KGV
- 15,0
- Gewinn je Aktie (TTM)
- 0,03
- Dividendenrendite
- 0,0 %
- Beta
- 0,4
- Nächste Zahlen
- –
Finanzen
| CNY | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Umsatz | 6 Mrd. | 5,83 Mrd. | 6,42 Mrd. | 6,2 Mrd. | 6,53 Mrd. |
| Herstellungskosten | 5,29 Mrd. | 5,1 Mrd. | 5,76 Mrd. | 5,51 Mrd. | 5,87 Mrd. |
| Bruttogewinn | 713,91 Mio. | 733,41 Mio. | 662,69 Mio. | 680,91 Mio. | 661,78 Mio. |
| Forschung und Entwicklung | 1,01 Mio. | 1,01 Mio. | 798.000 | 721.000 | 1,36 Mio. |
| Vertrieb und Verwaltung | 650,18 Mio. | 640,03 Mio. | 586,53 Mio. | 571,89 Mio. | 541,94 Mio. |
| Operatives Ergebnis | 58,52 Mio. | 116,48 Mio. | 101,67 Mio. | 149,56 Mio. | 148,61 Mio. |
| EBITDA | 268,19 Mio. | 288,18 Mio. | 242,24 Mio. | 295,69 Mio. | 311,11 Mio. |
| Nettogewinn | −1,56 Mio. | 58,83 Mio. | 47,02 Mio. | 91,85 Mio. | 155,47 Mio. |
| Gewinn je Aktie (verwässert) | -0,00 | 0,06 | 0,05 | 0,09 | 0,08 |
Bewertung
Letzte 12 Monate
- KGV
- 15,0
- Kurs-Umsatz-Verhältnis
- 0,1
- Kurs-Buchwert-Verhältnis
- 0,2
- PEG
- -0,0
- Bruttomarge
- 12,4 %
- Operative Marge
- 1,6 %
- Nettomarge
- 0,6 %
- Verschuldungsgrad
- 0,2
- EV/EBITDA
- 1,2
- Eigenkapitalrendite
- 1,5 %
- Kapitalrendite (ROIC)
- 2,3 %
- Free-Cashflow-Rendite
- 0,0 %
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | |
|---|---|---|---|---|---|
| Bruttomarge | 11,9 % | 12,6 % | 10,3 % | 11,0 % | 10,1 % |
| Operative Marge | 1,0 % | 2,0 % | 1,6 % | 2,4 % | 2,3 % |
| Nettomarge | −0,0 % | 1,0 % | 0,7 % | 1,5 % | 2,4 % |
| KGV | -335,3 | 10,1 | 12,7 | 5,2 | 7,6 |
| Kurs-Umsatz-Verhältnis | 0,1 | 0,1 | 0,1 | 0,1 | 0,1 |
| Kurs-Buchwert-Verhältnis | 0,2 | 0,3 | 0,3 | 0,2 | 0,3 |
| Verschuldungsgrad | 0,2 | 0,3 | 0,3 | 0,2 | 0,2 |
| Liquidität 3. Grades | 1,7 | 1,5 | 1,6 | 2,0 | 2,3 |
| Dividendenrendite | 0,0 % | 0,0 % | 0,0 % | 9,9 % | 7,2 % |
| Unternehmenswert | 446,9 Mio. | 719,86 Mio. | 632,66 Mio. | 352,25 Mio. | 428,81 Mio. |
| EV/EBITDA | 1,7 | 2,5 | 2,6 | 1,2 | 1,4 |
| Eigenkapitalrendite | −0,1 % | 2,7 % | 2,2 % | 4,4 % | 7,8 % |
| Kapitalrendite (ROIC) | 1,0 % | 3,3 % | 3,0 % | 4,9 % | 5,1 % |
| Free-Cashflow-Rendite | 37,6 % | −10,6 % | −23,2 % | −7,2 % | 4,9 % |
Wachstum
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | |
|---|---|---|---|---|---|
| Umsatz | +2,9 % | −9,1 % | +3,6 % | −5,1 % | +6,2 % |
| Bruttogewinn | −2,7 % | +10,7 % | −2,7 % | +2,9 % | −7,3 % |
| Operatives Ergebnis | −49,8 % | +14,6 % | −32,0 % | +0,6 % | −27,4 % |
| Nettogewinn | −102,6 % | +25,1 % | −48,8 % | −40,9 % | −23,4 % |
| Gewinn je Aktie | −102,6 % | +25,1 % | −48,8 % | +14,7 % | +27,9 % |
| Freier Cashflow | +405,5 % | +54,7 % | −308,3 % | −213,3 % | −92,0 % |
| Dividende je Aktie | 0,0 % | 0,0 % | −100,0 % | +6,1 % | +6,1 % |
Analysten
Einstufungen
Gerade nicht verfügbar.
Kursziel
Gerade nicht verfügbar.
Quartalszahlen
| Dez. 2025 | Sept. 2024 | Juni 2024 | Juni 2024 | März 2024 | Nov. 2023 | Aug. 2023 | Apr. 2023 | |
|---|---|---|---|---|---|---|---|---|
| Gewinn je Aktie · Erwartet | – | – | – | – | – | – | – | – |
| Gewinn je Aktie · Tatsächlich | 0,01 | 0,01 | 0,01 | 0,03 | -0,02 | 0,03 | 0,03 | 0,01 |
| Abweichung | – | – | – | – | – | – | – | – |
| Umsatz · Tatsächlich | 1,65 Mrd. | 1,68 Mrd. | 1,49 Mrd. | 1,52 Mrd. | 1,75 Mrd. | 1,81 Mrd. | 1,74 Mrd. | 1,75 Mrd. |
Dividenden und Splits
| Ex-Tag | Zahltag | Betrag |
|---|---|---|
| 4. Juli 2012 | 12. Juli 2012 | 0,09 |
| 20. Juni 2011 | 7. Juli 2011 | 0,04 |
| 24. Mai 2010 | 10. Juni 2010 | 0,03 |
| 14. Mai 2009 | 8. Juni 2009 | 0,04 |
Aktiensplits
–
Eigentümer
Institutionen
Gerade nicht verfügbar.
Insider-Geschäfte
–
Vergleichbare Unternehmen
0464.HKChina In-Tech Limited0,515+0,98 %
0677.HKGolden Resources Development International Limited0,340,00 %
0809.HKGlobal Bio-chem Technology Group Company Limited0,33−4,35 %
0829.HKShenguan Holdings (Group) Limited0,28+3,70 %
0834.HKShengrong Holding Ltd0,217−0,91 %
1262.HKLabixiaoxin Snacks Group Limited4,25−1,16 %
1285.HKJiashili Group Limited1,395+4,49 %
1565.HKVirscend Education Company Limited0,1650,00 %
Über das Unternehmen
DaChan Food (Asia) Limited, operating alongside its various subsidiaries, is primarily engaged in the production and distribution of animal feeds, chilled and frozen poultry products, and a diverse range of processed food items. The company's operations are structured across three main divisions: Processed Food, Livestock Feeds, and Chicken Meat. Within its Processed Food division, the company manufactures and supplies a variety of prepared food products, including pickled, pre-fried, and convenient instant meals. The Livestock Feeds segment focuses on creating and disseminating a wide array of nutritional products, such as complete feeds, base mixes, and premixes, designed for different types of farm animals including pigs, laying hens, broilers, ducks, and breeder poultry. These are marketed under established brands like Dr. Nupak, DaChan, and Green Knight. Its Chicken Meat segment encompasses the entire vertical integration of poultry production, from broiler farming and the hatching of breeder eggs to managing contract farming operations. This division also handles the processing and commercialization of both chilled and frozen chicken products, sold under the DaChan and Sisters' Kitchen labels. Beyond these core activities, the firm participates in animal husbandry, including the construction and rental of poultry facilities, as well as the breeding and sale of swine. Furthermore, it engages in the production and commerce of feed meals, associated additives, aquaculture products, and specialized veterinary and aquatic pharmaceuticals. DaChan Food (Asia) reaches its diverse customer base through multiple channels, including major retail chains, local farmers' markets, e-commerce platforms, independent distributors, and supermarkets. Its geographical footprint extends across the People's Republic of China, Vietnam, Malaysia, Japan, and other parts of the broader Asia Pacific region. Established in 2007, the company maintains its primary office in Beijing, China, and operates as a subsidiary of Great Wall International (Holdings) Ltd.
Führung
- Chun-Hsien WeiExecutive Chairman of the Board & Chief Executive Officer
- Chia-Yin HanExecutive Director
- Yung Hsu LanChief Financial Officer
- Yi Ping ChoCompany Secretary
- Yuxia FengHead of Legal Department
- CEO
- Chun-Hsien Wei
- Mitarbeitende
- 8.396
- Hauptsitz
- Beijing, BE, CN
- Sektor
- Consumer Defensive
- Branche
- Packaged Foods
- Börsengang
- 4. Okt. 2007
- Website
- dfa3999.com
Nachrichten
Gerade keine Nachrichten zu diesem Unternehmen.
Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.